FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Device Security Should Start in Design: FDA

[ Price : $8.95]

CDRH associate director Suzanne Schwartz says medical device manufacturers should build cyber security into their devices at the d...

ICH Genomic Sampling Guidance to be Implemented

[ Price : $8.95]

FDA says an ICH guidance on genomic sampling and data has passed Step 4 and is being implemented.

Court Says Essure Suit is Preempted

[ Price : $8.95]

Attorney Rachel Weil says a New Your federal court has ruled that a liability suit against Bayer over its Essure birth control dev...

FDA Approves Mvasi Biosimilar of Avastin

[ Price : $8.95]

FDA approves Amgens Mvasi, a biosimilar to Genentechs Avastin, for treating multiple forms of cancer.

In Vitro Diagnostic Device Characteristics Guidance

[ Price : $8.95]

FDA issues a guidance to facilitate study designs establishing performance characteristics of in vitro diagnostic devices intended...

FDA Approves Expanded COPD Use for Symbicort

[ Price : $8.95]

FDA approves AstraZenecas asthma therapy Symbicort (budesonide/formoterol fumarate dihydrate) inhalation aerosol 160/4.5 microgram...

Mobile Medical App Cleared for Substance Use Disorder

[ Price : $8.95]

FDA permits under its de novo process the marketing of the first mobile medical application to help treat substance use disorders.

Microneedling Device Guidance Out

[ Price : $8.95]

FDA releases a draft guidance to help industry know when a microneedling product is legally considered a medical device subject to...

Drug/Biologic User Fees for FY 2018

[ Price : $8.95]

Federal Register notice: FDA announces the rates for prescription drug user fees for fiscal year 2018.

Biosimilar User Fee Rates for FY 2018

[ Price : $8.95]

Federal Register notice: FDA announces rates for biosimilar user fees for fiscal year 2018.